Michael Webb

Dr. Michael Webb

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BWBrendan J. Wall
Brendan J. Wall
MWMark F. Will
Mark F. Will
GYGideon K. Yawson
Gideon K. Yawson
PBPaige J. Bothwell
Paige J. Bothwell
DPDavid C. Platt
David C. Platt
MWMichael Webb
Michael Webb

1 April 2020 in Metallomics
Verified
Journal Article
Open access
PDF file
SHSamantha E Huffman
Samantha E Huffman
GYGideon K Yawson
Gideon K Yawson
SFSamuel S Fisher
Samuel S Fisher
PBPaige J Bothwell
Paige J Bothwell
DPDavid C Platt
David C Platt
MWMichael Webb
Michael Webb
Alzheimer’s Disease (AD) is a devastating neurodegenerative disorder where one of the commonly observed pathological hallmarks is extracellular deposits of the peptide amyloid-β (Aβ). These deposits contain a high concentration of metals and initially presented a promising target for therapy; however it has become increasingly evident that the soluble form of the peptide is neurotoxic, not the amyloidogenic species. Metal-based therapeutics are uniquely suited to target soluble Aβ and have shown considerable promise to prevent the aggregation and induced cytotoxicity of the peptide in vitro. Herein, we have prepared a small series of derivatives of two promising Ru(iii) complexes NAMI-A (imidazolium [trans-RuCl4(1H-imidazole)(dimethyl sulfoxide-S)]) and PMRU20 (2-aminothiazolium [trans-RuCl4(2-aminothiazole)2]), to determine structure–activity relationships (SAR) for Ru(iii) therapeutics for AD. Using the three complementary methods of Thioflavin T fluorescence, dynamic light scattering (DLS), and transmission electron microscopy (TEM), it was determined that the symmetry around the metal center did not significantly impact the activity of the complexes, but rather the attached thiazole ligand(s) mitigated Aβ aggregation. Across both families of Ru(iii) complexes the determined SAR for the functional groups on the thiazole ligands to modulate Aβ aggregation were NH2 > CH3 > H. These results highlight the importance of secondary interactions between the metallotherapeutic and the Aβ peptide where hydrogen-bonding has the greatest impact on modulating Aβ aggregation.

1 January 2021 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
GYGideon K. Yawson
Gideon K. Yawson
SHSamantha E. Huffman
Samantha E. Huffman
SFSamuel S. Fisher
Samuel S. Fisher
PBPaige J. Bothwell
Paige J. Bothwell
DPDavid C. Platt
David C. Platt
MWMichael Webb
Michael Webb

1 February 2022 in Inorganic Chemistry
Verified
Journal Article
Closed access
GYGideon K. Yawson
Gideon K. Yawson
MWMark F. Will
Mark F. Will
SHSamantha E. Huffman
Samantha E. Huffman
ESEvan T. Strandquist
Evan T. Strandquist
PBPaige J. Bothwell
Paige J. Bothwell
MWMichael Webb
Michael Webb

4 November 2022 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
SMStephen Mensah
Stephen Mensah
JRJoseph D. Rosenthal
Joseph D. Rosenthal
MDMamta Dagar
Mamta Dagar
TBTyson Brown
Tyson Brown
JMJonathan J. Mills
Jonathan J. Mills
MWMichael Webb
Michael Webb
The evolution of high virulence bacterial strains has necessitated the development of novel therapeutic agents to treat resistant infections. Metal-based therapeutics represent a promising avenue for advancement, given their structural variability and unique modes of action relative to classical organic molecules. One strategy that has seen marked success is the incorporation of ferrocene into the framework of established antibacterial agents, while ruthenium-based complexes have also shown promise as bioactive compounds. This work focused on the preparation of novel ruthenium(II)-arene complexes containing Schiff base ligands with an attached ferrocene, and evaluation of their antibacterial activity. Structure–activity relationships identified the importance of having a phenyl group between the Schiff base imine and the appended ferrocene. This complex, C2, showed prominent activity against several clinically relevant bacterial strains, including a minimum inhibitory concentration of 16 μg mL−1 for methicillin-resistant Staphylococcus aureus (MSRA). Overall, the results of this study represent a promising new lead for future development of novel antibacterial agents.

7 November 2023 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
JEJohanna T. Ehlbeck
Johanna T. Ehlbeck
DGDaniela M. Grimard
Daniela M. Grimard
RHRyan M. Hacker
Ryan M. Hacker
JGJimmy A. Garcia
Jimmy A. Garcia
BWBrendan J. Wall
Brendan J. Wall
MWMichael Webb
Michael Webb